Skip to main content
PPN WorldPPN World
Create free account

PPN World · Archive

Reserved for subscribers

This release sits in the PPN World archive. Subscribers read the full wire as it lands — 80+ newswires, 190+ countries, searchable back through the archive, with alerts on the subjects they track.

  • Every release, the moment it crosses — not a daily digest
  • Search and filter the full archive, not the last 24 hours
  • Instant alerts on saved searches
Start reading →Already a subscriber? Sign in

PPN World — real-time press release intelligence.

Tagrisso plus Orpathys reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on Tagrisso · AstraZeneca — Press Releases · PPN World